Sanofi (SNY) Tax Rate (2009 - 2026)

Sanofi (SNY) posted Tax Rate of 3.16% for Q2 2026, up 7.17% sequentially from 3.41% in Q1 2026, and down 127.0% YoY from 11.71% in Q2 2025.

Sanofi (SNY) Tax Rate (2009 - 2026) Analysis & Trends

Sanofi has reported Tax Rate for 18 years, with the latest figure at 3.16% in Q2 2026.

Quarterly Tax Rate fell 127.0% year-over-year to 3.16% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 4.36% (up 171.0% YoY) and the FY2025 annual result came in at 16.89%, down 955.0% from the prior year.
Tax Rate advanced to 3.16% in Q2 2026 per SNY's latest filing, from 3.41% in the prior quarter.
Over five years, Tax Rate peaked at 0.96% in Q1 2024 and troughed at 26.44% in Q4 2024.
A 5-year average of 4.71% and a median of 3.28% in 2026 frame the typical range for Tax Rate.
The sharpest annual moves came in 2022 and 2025: Tax Rate slumped 1067400 bps in 2022, then surged 1692 bps in 2025.
Over 5 years, Tax Rate stood at 2.76% in 2022, then advanced by 20 bps to 2.22% in 2023, then sank by 1089 bps to 26.44% in 2024, then surged by 64 bps to 9.52% in 2025, then jumped by 67 bps to 3.16% in 2026.
According to Business Quant data, Tax Rate over the past three periods registered 3.16%, 3.41%, and 9.52% for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	17.98%
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	15.47%
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	-95.75%
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	23.71%
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	10.40%
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	14.20%
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	-2.36%
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	62.33%
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	56.21%
10	Sanofi	55.07 Bn	47.69 Bn	10.79 Bn	-3.05%

Download Data